In randomized trials to prevent breast milk transmission of human immunodeficiency virus (HIV) from mother to infant, investigators are often interested in assessing the effect of a treatment or intervention on the cumulative risk of HIV infection by time (age) t in infants who are alive and uninfected at a certain time point τ0 τ0 within the principal stratum of infants who would be alive and uninfected by τ0 regardless of randomization assignment. Large sample non-parametric bounds and a semi-parametric sensitivity analysis model are developed for drawing inference about this causal effect. A simulation study is presented demonstrating that the proposed methods perform well in finite samples. The proposed methods are applied to a large, ...
Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic b...
Assessing per-protocol treatment effcacy on a time-to-event endpoint is a common objective of random...
OBJECTIVES: To determine the optimal time for a second HIV-1 nucleic acid amplification assay to det...
In randomized trials to prevent breast milk transmission of human immunodeficiency virus (HIV) from ...
Establishing statistical methods for quantifying the effects of interventions to prevent infectious ...
Infectious disease prevention studies often aim to test or estimate the "causal effect" of a prevent...
SUMMARY. In many experiments researchers would like to compare between treatments an outcome that on...
In this paper, we present a model for imputing timing of mother-to- child transmission (MTCT) of HIV...
International audiencePostnatal transmission of human immunodeficiency virus infection through breas...
Thesis (Ph. D.)--University of Washington, 2005.In many experiments researchers would like to compar...
In randomized studies, treatment comparisons conditional on intermediate post-randomization outcomes...
Worldwide, particularly in areas with no treatment availability or antenatal programs, approximately...
Background: To assess the impact of Option B+ on the 18- month’s outcomes of HIV-exposed infants (HE...
Thesis (Ph.D.)--University of Washington, 2013In this dissertation, we present a new model that acco...
Background: The success of any prevention of mother-to-child transmission (PMTCT) program is assesse...
Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic b...
Assessing per-protocol treatment effcacy on a time-to-event endpoint is a common objective of random...
OBJECTIVES: To determine the optimal time for a second HIV-1 nucleic acid amplification assay to det...
In randomized trials to prevent breast milk transmission of human immunodeficiency virus (HIV) from ...
Establishing statistical methods for quantifying the effects of interventions to prevent infectious ...
Infectious disease prevention studies often aim to test or estimate the "causal effect" of a prevent...
SUMMARY. In many experiments researchers would like to compare between treatments an outcome that on...
In this paper, we present a model for imputing timing of mother-to- child transmission (MTCT) of HIV...
International audiencePostnatal transmission of human immunodeficiency virus infection through breas...
Thesis (Ph. D.)--University of Washington, 2005.In many experiments researchers would like to compar...
In randomized studies, treatment comparisons conditional on intermediate post-randomization outcomes...
Worldwide, particularly in areas with no treatment availability or antenatal programs, approximately...
Background: To assess the impact of Option B+ on the 18- month’s outcomes of HIV-exposed infants (HE...
Thesis (Ph.D.)--University of Washington, 2013In this dissertation, we present a new model that acco...
Background: The success of any prevention of mother-to-child transmission (PMTCT) program is assesse...
Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic b...
Assessing per-protocol treatment effcacy on a time-to-event endpoint is a common objective of random...
OBJECTIVES: To determine the optimal time for a second HIV-1 nucleic acid amplification assay to det...